▶ 調査レポート

世界のアルファシヌクレイン市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Alpha Synuclein Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のアルファシヌクレイン市場 2021:企業別、地域別、種類・用途別 / Global Alpha Synuclein Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-107A14362資料のイメージです。• レポートコード:GIR-107A14362
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、アルファシヌクレインのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルファシヌクレインの種類別市場規模(AV-1950R、AV-1947D、BAN-0805、BIIB-054、DPC-003、その他)、用途別市場規模(多系統萎縮症、神経変性疾患、レビー小体型認知症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・アルファシヌクレインの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):AC Immune SA、AFFiRiS AG、BioArctic AB、Biogen Inc、Evotec AG、Genmab A/S、H. Lundbeck A/S、ICB International Inc、MedImmune LLC、Neuropore Therapies Inc、nLife Therapeutics SL、Prothena Corp Plc、QR Pharma Inc、reMYND NV
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:AV-1950R、AV-1947D、BAN-0805、BIIB-054、DPC-003、その他
・用途別分析2016年-2026年:多系統萎縮症、神経変性疾患、レビー小体型認知症、その他
・アルファシヌクレインの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・アルファシヌクレインのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・アルファシヌクレインのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・アルファシヌクレインの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・アルファシヌクレインの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Alpha Synuclein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Alpha Synuclein size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Alpha Synuclein market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Alpha Synuclein market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
AV-1950R
AV-1947D
BAN-0805
BIIB-054
DPC-003
Others

Market segment by Application can be divided into
Multiple System Atrophy
Neurodegenerateive Disease
Lewy Body Dementia
Others

The key market players for global Alpha Synuclein market are listed below:
AC Immune SA
AFFiRiS AG
BioArctic AB
Biogen Inc
Evotec AG
Genmab A/S
H. Lundbeck A/S
ICB International Inc
MedImmune LLC
Neuropore Therapies Inc
nLife Therapeutics SL
Prothena Corp Plc
QR Pharma Inc
reMYND NV

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Alpha Synuclein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alpha Synuclein, with price, sales, revenue and global market share of Alpha Synuclein from 2019 to 2021.
Chapter 3, the Alpha Synuclein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha Synuclein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Alpha Synuclein market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Alpha Synuclein sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Alpha Synuclein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alpha Synuclein Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 AV-1950R
1.2.3 AV-1947D
1.2.4 BAN-0805
1.2.5 BIIB-054
1.2.6 DPC-003
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Alpha Synuclein Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Multiple System Atrophy
1.3.3 Neurodegenerateive Disease
1.3.4 Lewy Body Dementia
1.3.5 Others
1.4 Global Alpha Synuclein Market Size & Forecast
1.4.1 Global Alpha Synuclein Sales in Value (2016-2026))
1.4.2 Global Alpha Synuclein Sales in Volume (2016-2026)
1.4.3 Global Alpha Synuclein Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Alpha Synuclein Production Capacity Analysis
1.5.1 Global Alpha Synuclein Total Production Capacity (2016-2026)
1.5.2 Global Alpha Synuclein Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alpha Synuclein Market Drivers
1.6.2 Alpha Synuclein Market Restraints
1.6.3 Alpha Synuclein Trends Analysis
2 Manufacturers Profiles
2.1 AC Immune SA
2.1.1 AC Immune SA Details
2.1.2 AC Immune SA Major Business
2.1.3 AC Immune SA Alpha Synuclein Product and Services
2.1.4 AC Immune SA Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AFFiRiS AG
2.2.1 AFFiRiS AG Details
2.2.2 AFFiRiS AG Major Business
2.2.3 AFFiRiS AG Alpha Synuclein Product and Services
2.2.4 AFFiRiS AG Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 BioArctic AB
2.3.1 BioArctic AB Details
2.3.2 BioArctic AB Major Business
2.3.3 BioArctic AB Alpha Synuclein Product and Services
2.3.4 BioArctic AB Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Biogen Inc
2.4.1 Biogen Inc Details
2.4.2 Biogen Inc Major Business
2.4.3 Biogen Inc Alpha Synuclein Product and Services
2.4.4 Biogen Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Evotec AG
2.5.1 Evotec AG Details
2.5.2 Evotec AG Major Business
2.5.3 Evotec AG Alpha Synuclein Product and Services
2.5.4 Evotec AG Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Genmab A/S
2.6.1 Genmab A/S Details
2.6.2 Genmab A/S Major Business
2.6.3 Genmab A/S Alpha Synuclein Product and Services
2.6.4 Genmab A/S Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 H. Lundbeck A/S
2.7.1 H. Lundbeck A/S Details
2.7.2 H. Lundbeck A/S Major Business
2.7.3 H. Lundbeck A/S Alpha Synuclein Product and Services
2.7.4 H. Lundbeck A/S Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 ICB International Inc
2.8.1 ICB International Inc Details
2.8.2 ICB International Inc Major Business
2.8.3 ICB International Inc Alpha Synuclein Product and Services
2.8.4 ICB International Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 MedImmune LLC
2.9.1 MedImmune LLC Details
2.9.2 MedImmune LLC Major Business
2.9.3 MedImmune LLC Alpha Synuclein Product and Services
2.9.4 MedImmune LLC Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Neuropore Therapies Inc
2.10.1 Neuropore Therapies Inc Details
2.10.2 Neuropore Therapies Inc Major Business
2.10.3 Neuropore Therapies Inc Alpha Synuclein Product and Services
2.10.4 Neuropore Therapies Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 nLife Therapeutics SL
2.11.1 nLife Therapeutics SL Details
2.11.2 nLife Therapeutics SL Major Business
2.11.3 nLife Therapeutics SL Alpha Synuclein Product and Services
2.11.4 nLife Therapeutics SL Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Prothena Corp Plc
2.12.1 Prothena Corp Plc Details
2.12.2 Prothena Corp Plc Major Business
2.12.3 Prothena Corp Plc Alpha Synuclein Product and Services
2.12.4 Prothena Corp Plc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 QR Pharma Inc
2.13.1 QR Pharma Inc Details
2.13.2 QR Pharma Inc Major Business
2.13.3 QR Pharma Inc Alpha Synuclein Product and Services
2.13.4 QR Pharma Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 reMYND NV
2.14.1 reMYND NV Details
2.14.2 reMYND NV Major Business
2.14.3 reMYND NV Alpha Synuclein Product and Services
2.14.4 reMYND NV Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Alpha Synuclein Sales by Manufacturer
3.1 Global Alpha Synuclein Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Alpha Synuclein Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Alpha Synuclein
3.4 Market Concentration Rate
3.4.1 Top 3 Alpha Synuclein Manufacturer Market Share
3.4.2 Top 6 Alpha Synuclein Manufacturer Market Share
3.5 Global Alpha Synuclein Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Alpha Synuclein Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alpha Synuclein Market Size by Region
4.1.1 Global Alpha Synuclein Sales in Volume by Region (2016-2026)
4.1.2 Global Alpha Synuclein Revenue by Region (2016-2026)
4.2 North America Alpha Synuclein Revenue (2016-2026)
4.3 Europe Alpha Synuclein Revenue (2016-2026)
4.4 Asia-Pacific Alpha Synuclein Revenue (2016-2026)
4.5 South America Alpha Synuclein Revenue (2016-2026)
4.6 Middle East and Africa Alpha Synuclein Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Alpha Synuclein Sales in Volume by Type (2016-2026)
5.2 Global Alpha Synuclein Revenue by Type (2016-2026)
5.3 Global Alpha Synuclein Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Alpha Synuclein Sales in Volume by Application (2016-2026)
6.2 Global Alpha Synuclein Revenue by Application (2016-2026)
6.3 Global Alpha Synuclein Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Alpha Synuclein Sales by Type (2016-2026)
7.2 North America Alpha Synuclein Sales by Application (2016-2026)
7.3 North America Alpha Synuclein Market Size by Country
7.3.1 North America Alpha Synuclein Sales in Volume by Country (2016-2026)
7.3.2 North America Alpha Synuclein Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Alpha Synuclein Sales by Type (2016-2026)
8.2 Europe Alpha Synuclein Sales by Application (2016-2026)
8.3 Europe Alpha Synuclein Market Size by Country
8.3.1 Europe Alpha Synuclein Sales in Volume by Country (2016-2026)
8.3.2 Europe Alpha Synuclein Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Alpha Synuclein Sales by Type (2016-2026)
9.2 Asia-Pacific Alpha Synuclein Sales by Application (2016-2026)
9.3 Asia-Pacific Alpha Synuclein Market Size by Region
9.3.1 Asia-Pacific Alpha Synuclein Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Alpha Synuclein Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Alpha Synuclein Sales by Type (2016-2026)
10.2 South America Alpha Synuclein Sales by Application (2016-2026)
10.3 South America Alpha Synuclein Market Size by Country
10.3.1 South America Alpha Synuclein Sales in Volume by Country (2016-2026)
10.3.2 South America Alpha Synuclein Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alpha Synuclein Sales by Type (2016-2026)
11.2 Middle East & Africa Alpha Synuclein Sales by Application (2016-2026)
11.3 Middle East & Africa Alpha Synuclein Market Size by Country
11.3.1 Middle East & Africa Alpha Synuclein Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Alpha Synuclein Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Alpha Synuclein Typical Distributors
12.3 Alpha Synuclein Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Alpha Synuclein Revenue by Type, (USD Million), 2021-2026
Table 2. Global Alpha Synuclein Revenue by Application, (USD Million), 2021-2026
Table 3. AC Immune SA Basic Information, Manufacturing Base and Competitors
Table 4. AC Immune SA Major Business
Table 5. AC Immune SA Alpha Synuclein Product and Services
Table 6. AC Immune SA Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AFFiRiS AG Basic Information, Manufacturing Base and Competitors
Table 8. AFFiRiS AG Major Business
Table 9. AFFiRiS AG Alpha Synuclein Product and Services
Table 10. AFFiRiS AG Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. BioArctic AB Basic Information, Manufacturing Base and Competitors
Table 12. BioArctic AB Major Business
Table 13. BioArctic AB Alpha Synuclein Product and Services
Table 14. BioArctic AB Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biogen Inc Basic Information, Manufacturing Base and Competitors
Table 16. Biogen Inc Major Business
Table 17. Biogen Inc Alpha Synuclein Product and Services
Table 18. Biogen Inc Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Evotec AG Basic Information, Manufacturing Base and Competitors
Table 20. Evotec AG Major Business
Table 21. Evotec AG Alpha Synuclein Product and Services
Table 22. Evotec AG Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Genmab A/S Basic Information, Manufacturing Base and Competitors
Table 24. Genmab A/S Major Business
Table 25. Genmab A/S Alpha Synuclein Product and Services
Table 26. Genmab A/S Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. H. Lundbeck A/S Basic Information, Manufacturing Base and Competitors
Table 28. H. Lundbeck A/S Major Business
Table 29. H. Lundbeck A/S Alpha Synuclein Product and Services
Table 30. H. Lundbeck A/S Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. ICB International Inc Basic Information, Manufacturing Base and Competitors
Table 32. ICB International Inc Major Business
Table 33. ICB International Inc Alpha Synuclein Product and Services
Table 34. ICB International Inc Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 36. MedImmune LLC Major Business
Table 37. MedImmune LLC Alpha Synuclein Product and Services
Table 38. MedImmune LLC Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Neuropore Therapies Inc Basic Information, Manufacturing Base and Competitors
Table 40. Neuropore Therapies Inc Major Business
Table 41. Neuropore Therapies Inc Alpha Synuclein Product and Services
Table 42. Neuropore Therapies Inc Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. nLife Therapeutics SL Basic Information, Manufacturing Base and Competitors
Table 44. nLife Therapeutics SL Major Business
Table 45. nLife Therapeutics SL Alpha Synuclein Product and Services
Table 46. nLife Therapeutics SL Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Prothena Corp Plc Basic Information, Manufacturing Base and Competitors
Table 48. Prothena Corp Plc Major Business
Table 49. Prothena Corp Plc Alpha Synuclein Product and Services
Table 50. Prothena Corp Plc Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. QR Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 52. QR Pharma Inc Major Business
Table 53. QR Pharma Inc Alpha Synuclein Product and Services
Table 54. QR Pharma Inc Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. reMYND NV Basic Information, Manufacturing Base and Competitors
Table 56. reMYND NV Major Business
Table 57. reMYND NV Alpha Synuclein Product and Services
Table 58. reMYND NV Alpha Synuclein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Alpha Synuclein Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 60. Global Alpha Synuclein Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Alpha Synuclein, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Alpha Synuclein Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 63. Head Office and Alpha Synuclein Production Site of Key Manufacturer
Table 64. Alpha Synuclein New Entrant and Capacity Expansion Plans
Table 65. Alpha Synuclein Mergers & Acquisitions in the Past Five Years
Table 66. Global Alpha Synuclein Sales by Region (2016-2021e) & (K Pcs)
Table 67. Global Alpha Synuclein Sales by Region (2021-2026) & (K Pcs)
Table 68. Global Alpha Synuclein Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Alpha Synuclein Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Alpha Synuclein Sales by Type (2016-2021e) & (K Pcs)
Table 71. Global Alpha Synuclein Sales by Type (2021-2026) & (K Pcs)
Table 72. Global Alpha Synuclein Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Alpha Synuclein Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Alpha Synuclein Price by Type (2016-2021e) & (USD/Pcs)
Table 75. Global Alpha Synuclein Price by Type (2021-2026) & (USD/Pcs)
Table 76. Global Alpha Synuclein Sales by Application (2016-2021e) & (K Pcs)
Table 77. Global Alpha Synuclein Sales by Application (2021-2026) & (K Pcs)
Table 78. Global Alpha Synuclein Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Alpha Synuclein Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Alpha Synuclein Price by Application (2016-2021e) & (USD/Pcs)
Table 81. Global Alpha Synuclein Price by Application (2021-2026) & (USD/Pcs)
Table 82. North America Alpha Synuclein Sales by Country (2016-2021e) & (K Pcs)
Table 83. North America Alpha Synuclein Sales by Country (2021-2026) & (K Pcs)
Table 84. North America Alpha Synuclein Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Alpha Synuclein Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Alpha Synuclein Sales by Type (2016-2021e) & (K Pcs)
Table 87. North America Alpha Synuclein Sales by Type (2021-2026) & (K Pcs)
Table 88. North America Alpha Synuclein Sales by Application (2016-2021e) & (K Pcs)
Table 89. North America Alpha Synuclein Sales by Application (2021-2026) & (K Pcs)
Table 90. Europe Alpha Synuclein Sales by Country (2016-2021e) & (K Pcs)
Table 91. Europe Alpha Synuclein Sales by Country (2021-2026) & (K Pcs)
Table 92. Europe Alpha Synuclein Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Alpha Synuclein Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Alpha Synuclein Sales by Type (2016-2021e) & (K Pcs)
Table 95. Europe Alpha Synuclein Sales by Type (2021-2026) & (K Pcs)
Table 96. Europe Alpha Synuclein Sales by Application (2016-2021e) & (K Pcs)
Table 97. Europe Alpha Synuclein Sales by Application (2021-2026) & (K Pcs)
Table 98. Asia-Pacific Alpha Synuclein Sales by Region (2016-2021e) & (K Pcs)
Table 99. Asia-Pacific Alpha Synuclein Sales by Region (2021-2026) & (K Pcs)
Table 100. Asia-Pacific Alpha Synuclein Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Alpha Synuclein Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Alpha Synuclein Sales by Type (2016-2021e) & (K Pcs)
Table 103. Asia-Pacific Alpha Synuclein Sales by Type (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Alpha Synuclein Sales by Application (2016-2021e) & (K Pcs)
Table 105. Asia-Pacific Alpha Synuclein Sales by Application (2021-2026) & (K Pcs)
Table 106. South America Alpha Synuclein Sales by Country (2016-2021e) & (K Pcs)
Table 107. South America Alpha Synuclein Sales by Country (2021-2026) & (K Pcs)
Table 108. South America Alpha Synuclein Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Alpha Synuclein Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Alpha Synuclein Sales by Type (2016-2021e) & (K Pcs)
Table 111. South America Alpha Synuclein Sales by Type (2021-2026) & (K Pcs)
Table 112. South America Alpha Synuclein Sales by Application (2016-2021e) & (K Pcs)
Table 113. South America Alpha Synuclein Sales by Application (2021-2026) & (K Pcs)
Table 114. Middle East & Africa Alpha Synuclein Sales by Country (2016-2021e) & (K Pcs)
Table 115. Middle East & Africa Alpha Synuclein Sales by Country (2021-2026) & (K Pcs)
Table 116. Middle East & Africa Alpha Synuclein Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Alpha Synuclein Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Alpha Synuclein Sales by Type (2016-2021e) & (K Pcs)
Table 119. Middle East & Africa Alpha Synuclein Sales by Type (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Alpha Synuclein Sales by Application (2016-2021e) & (K Pcs)
Table 121. Middle East & Africa Alpha Synuclein Sales by Application (2021-2026) & (K Pcs)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Alpha Synuclein Typical Distributors
Table 125. Alpha Synuclein Typical Customers
List of Figures
Figure 1. Alpha Synuclein Picture
Figure 2. Global Alpha Synuclein Sales Market Share by Type in 2020
Figure 3. AV-1950R
Figure 4. AV-1947D
Figure 5. BAN-0805
Figure 6. BIIB-054
Figure 7. DPC-003
Figure 8. Others
Figure 9. Global Alpha Synuclein Sales Market Share by Application in 2020
Figure 10. Multiple System Atrophy
Figure 11. Neurodegenerateive Disease
Figure 12. Lewy Body Dementia
Figure 13. Others
Figure 14. Global Alpha Synuclein Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Alpha Synuclein Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Alpha Synuclein Sales (2016-2026) & (K Pcs)
Figure 17. Global Alpha Synuclein Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Alpha Synuclein Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Alpha Synuclein Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Alpha Synuclein Market Drivers
Figure 21. Alpha Synuclein Market Restraints
Figure 22. Alpha Synuclein Market Trends
Figure 23. Global Alpha Synuclein Sales Market Share by Manufacturer in 2020
Figure 24. Global Alpha Synuclein Revenue Market Share by Manufacturer in 2020
Figure 25. Alpha Synuclein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Alpha Synuclein Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Alpha Synuclein Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Alpha Synuclein Sales Market Share by Region (2016-2026)
Figure 29. Global Alpha Synuclein Revenue Market Share by Region (2016-2026)
Figure 30. North America Alpha Synuclein Revenue (2016-2026) & (USD Million)
Figure 31. Europe Alpha Synuclein Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Alpha Synuclein Revenue (2016-2026) & (USD Million)
Figure 33. South America Alpha Synuclein Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Alpha Synuclein Revenue (2016-2026) & (USD Million)
Figure 35. Global Alpha Synuclein Sales Market Share by Type (2016-2026)
Figure 36. Global Alpha Synuclein Revenue Market Share by Type (2016-2026)
Figure 37. Global Alpha Synuclein Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Alpha Synuclein Sales Market Share by Application (2016-2026)
Figure 39. Global Alpha Synuclein Revenue Market Share by Application (2016-2026)
Figure 40. Global Alpha Synuclein Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Alpha Synuclein Sales Market Share by Type (2016-2026)
Figure 42. North America Alpha Synuclein Sales Market Share by Application (2016-2026)
Figure 43. North America Alpha Synuclein Sales Market Share by Country (2016-2026)
Figure 44. North America Alpha Synuclein Revenue Market Share by Country (2016-2026)
Figure 45. United States Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Alpha Synuclein Sales Market Share by Type (2016-2026)
Figure 49. Europe Alpha Synuclein Sales Market Share by Application (2016-2026)
Figure 50. Europe Alpha Synuclein Sales Market Share by Country (2016-2026)
Figure 51. Europe Alpha Synuclein Revenue Market Share by Country (2016-2026)
Figure 52. Germany Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Alpha Synuclein Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Alpha Synuclein Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Alpha Synuclein Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Alpha Synuclein Revenue Market Share by Region (2016-2026)
Figure 61. China Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Alpha Synuclein Sales Market Share by Type (2016-2026)
Figure 68. South America Alpha Synuclein Sales Market Share by Application (2016-2026)
Figure 69. South America Alpha Synuclein Sales Market Share by Country (2016-2026)
Figure 70. South America Alpha Synuclein Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Alpha Synuclein Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Alpha Synuclein Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Alpha Synuclein Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Alpha Synuclein Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Alpha Synuclein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source